Renal News
Renal News articles are provided via external RSS feeds.
Latest Articles
Kidney Transplants Less Successful At Night
Urology / Nephrology News From Medical News Today : July 18, 2008
Kidney transplants should be carried out during the day if possible. At least this is the conclusion suggested by a survey just published by urologists and internists at the University of Bonn (Transplantation Proceedings, vol. 40, p. 1341 ff.). Hence operations carried out at night require a further operation more than twice as often as other operations. Moreover, the risk of premature failure of the transplant is higher with operations taking place at night.
Kidney Damage Caused By Iodinated Contrast Material Thought To Be Overestimated
Urology / Nephrology News From Medical News Today : July 18, 2008
The use of iodinated contrast material may be less damaging to the kidneys than previously recorded, according to a recent study conducted by researchers at Columbia University Medical Center in New York, NY. "We reviewed patient records to determine the frequency and magnitude of serum creatinine changes in patients who had not received iodinated contrast material.
Dendreon Initiates Phase 2 Trial Of PROVENGE In Patients With Localized Prostate Cancer Prior To Surgery
Urology / Nephrology News From Medical News Today : July 18, 2008
Dendreon Corporation (Nasdaq: DNDN) announced that the Company has initiated a Phase 2 trial of PROVENGE(R) (sipuleucel-T), Dendreon's investigational active cellular immunotherapy for the treatment of prostate cancer, in men with localized prostate cancer who are scheduled to undergo a radical prostatectomy.
Both Metrifonate And Praziquantel Can Be Used To Combat Urinary Schistosomiasis
Urology / Nephrology News From Medical News Today : July 18, 2008
In 2000 the World Health Organization (WHO) stopped recommending metrifonate for treating urinary schistosomiasis because the drug did not appear to be as effective as the treatment of choice, praziquantel. Now a systematic review published in the latest edition of The Cochrane Library indicates that both metrifonate and praziquantel are effective at treating the infection.
Long-Acting Insulins in Type 1 Diabetes Safer Than Traditional Agents
MedPage Today Nephrology : July 18, 2008
HAIFA, Israel -- For type 1 diabetes, long-acting insulins such as glargine (Lantus) reduce severe hypoglycemic episodes but don't offer clinically significant improved glycemic control, according to a meta-analysis.
Kidney Damage Caused By Iodinated Contrast Material Thought To Be Overestimated
Urology / Nephrology News From Medical News Today : July 18, 2008
The use of iodinated contrast material may be less damaging to the kidneys than previously recorded, according to a recent study conducted by researchers at Columbia University Medical Center in New York, NY. "We reviewed patient records to determine the frequency and magnitude of serum creatinine changes in patients who had not received iodinated contrast material.
Dendreon Initiates Phase 2 Trial Of PROVENGE In Patients With Localized Prostate Cancer Prior To Surgery
Urology / Nephrology News From Medical News Today : July 18, 2008
Dendreon Corporation (Nasdaq: DNDN) announced that the Company has initiated a Phase 2 trial of PROVENGE(R) (sipuleucel-T), Dendreon's investigational active cellular immunotherapy for the treatment of prostate cancer, in men with localized prostate cancer who are scheduled to undergo a radical prostatectomy.
Both Metrifonate And Praziquantel Can Be Used To Combat Urinary Schistosomiasis
Urology / Nephrology News From Medical News Today : July 18, 2008
In 2000 the World Health Organization (WHO) stopped recommending metrifonate for treating urinary schistosomiasis because the drug did not appear to be as effective as the treatment of choice, praziquantel. Now a systematic review published in the latest edition of The Cochrane Library indicates that both metrifonate and praziquantel are effective at treating the infection.
Long-Acting Insulins in Type 1 Diabetes Safer Than Traditional Agents
MedPage Today Nephrology : July 18, 2008
HAIFA, Israel -- For type 1 diabetes, long-acting insulins such as glargine (Lantus) reduce severe hypoglycemic episodes but don't offer clinically significant improved glycemic control, according to a meta-analysis.
Intravenous Gammaglobulin (IVIG) Plus Rituximab Improves Chances For Successful Kidney Transplantation In High Immunologic-risk Patients
Urology / Nephrology News From Medical News Today : July 17, 2008
A new therapy developed at Cedars-Sinai Medical Center improves transplant rates and outcomes for patients awaiting living- and deceased-donor kidney transplantation, according to a study published in the July 17 issue of the New England Journal of Medicine.
Climate Change Means More Kidney Stones Say Scientists
Urology / Nephrology News From Medical News Today : July 17, 2008
US researchers say that kidney stones may become more common as the temperature rises across North America and causes more people to become dehydrated. The study is the work of researchers at the University of Texas (UT) Southwestern Medical Center at Dallas, and is published in the 15th July issue of the Proceedings of the National Academy of Sciences (PNAS).
Kidney Transplant Outcome Improved in High-Risk Patients
MedPage Today Nephrology : July 17, 2008
LOS ANGELES -- The prospect of a successful kidney transplant for sensitized patients with high anti-HLA antibody levels improves by a combination of intravenous immune globulin and rituximab (Rituxan), researchers here said.
Climate Change Means More Kidney Stones Say Scientists
Urology / Nephrology News From Medical News Today : July 17, 2008
US researchers say that kidney stones may become more common as the temperature rises across North America and causes more people to become dehydrated. The study is the work of researchers at the University of Texas (UT) Southwestern Medical Center at Dallas, and is published in the 15th July issue of the Proceedings of the National Academy of Sciences (PNAS).
Kidney Transplant Outcome Improved in High-Risk Patients
MedPage Today Nephrology : July 17, 2008
LOS ANGELES -- The prospect of a successful kidney transplant for sensitized patients with high anti-HLA antibody levels improves by a combination of intravenous immune globulin and rituximab (Rituxan), researchers here said.
Increased Risk Of Kidney Stone Disease Due To Global Warming, Predicts UT Southwestern Researchers
Urology / Nephrology News From Medical News Today : July 16, 2008
Global warming is likely to increase the proportion of the population affected by kidney stones by expanding the higher-risk region known as the "kidney-stone belt" into neighboring states, researchers at UT Southwestern Medical Center and UT Dallas have found. Dehydration is one of the risk factors linked to kidney-stone disease, and the paper suggests global warming will exacerbate this effect. The researchers predict that by 2050, higher temperatures will cause an additional 1.
Positive Top-Line Results For Denosumab Treatment Of Bone Loss In Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy
Urology / Nephrology News From Medical News Today : July 16, 2008
Amgen (NASDAQ: AMGN) announced findings from a three-year pivotal Phase 3 placebo-controlled trial evaluating denosumab in the treatment of bone loss in men undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer.
Diabetes Increases Risk of Active TB
MedPage Today Nephrology : July 16, 2008
BOSTON -- Diabetes together with a tuberculosis infection increases the risk of active TB by a factor of three, researchers here said.
Increased Risk Of Kidney Stone Disease Due To Global Warming, Predicts UT Southwestern Researchers
Urology / Nephrology News From Medical News Today : July 16, 2008
Global warming is likely to increase the proportion of the population affected by kidney stones by expanding the higher-risk region known as the "kidney-stone belt" into neighboring states, researchers at UT Southwestern Medical Center and UT Dallas have found. Dehydration is one of the risk factors linked to kidney-stone disease, and the paper suggests global warming will exacerbate this effect. The researchers predict that by 2050, higher temperatures will cause an additional 1.
Positive Top-Line Results For Denosumab Treatment Of Bone Loss In Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy
Urology / Nephrology News From Medical News Today : July 16, 2008
Amgen (NASDAQ: AMGN) announced findings from a three-year pivotal Phase 3 placebo-controlled trial evaluating denosumab in the treatment of bone loss in men undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer.
Diabetes Increases Risk of Active TB
MedPage Today Nephrology : July 16, 2008
BOSTON -- Diabetes together with a tuberculosis infection increases the risk of active TB by a factor of three, researchers here said.
Prehypertension in Youth Increases Atherosclerosis in Middle Age
MedPage Today Nephrology : July 15, 2008
SAN FRANCISCO -- Modestly elevated blood pressure in young adults may damage their vascular health beyond the increased risks of hypertension later in life, researchers found.
Theragenics Corporation(R) Engages Men In A National Debate On Prostate Cancer
Urology / Nephrology News From Medical News Today : July 15, 2008
Theragenics Corporation, a medical device Company serving the prostate cancer and surgical markets (NYSE: TGX), is challenging men to engage in a national debate surrounding the treatment of the disease that will affect one in six of them - prostate cancer. This week, the Company announced its latest campaign to promote awareness of proven prostate cancer treatment options, "The Great Prostate Debate.
Theragenics Corporation(R) Engages Men In A National Debate On Prostate Cancer
Urology / Nephrology News From Medical News Today : July 15, 2008
Theragenics Corporation, a medical device Company serving the prostate cancer and surgical markets (NYSE: TGX), is challenging men to engage in a national debate surrounding the treatment of the disease that will affect one in six of them - prostate cancer. This week, the Company announced its latest campaign to promote awareness of proven prostate cancer treatment options, "The Great Prostate Debate.
Lowering Blood Pressure May Reduce Dementia in the Elderly
MedPage Today Nephrology : July 10, 2008
LONDON -- For patients ages 80 or older, hypertension treatment may afford a small reduction in dementia risk, researchers found.
Cardiac Benefits with Hypertension Treatment Vary by Gender
MedPage Today Nephrology : July 04, 2008
NEW YORK -- In patients receiving treatment for hypertension, women have less improvement in left ventricular hypertrophy than men, a post hoc analysis revealed.
